Impact of COVID-19 Outbreak on Clinical Trials of Drugs and Vaccines, Global Market Research Report 2020

Impact of COVID-19 Outbreak on Clinical Trials of Drugs and Vaccines, Global Market Research Report 2020

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Clinical Trials of Drugs and Vaccines Revenue
1.4 Market Analysis by Type
1.4.1 Global Clinical Trials of Drugs and Vaccines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Phase I
1.4.3 Phase II
1.4.4 Phase III
1.4.5 Phase IV
1.5 Market by Application
1.5.1 Global Clinical Trials of Drugs and Vaccines Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical Industry
1.5.3 Hospital
1.5.4 Laboratory
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Clinical Trials of Drugs and Vaccines Industry Impact
1.6.1 How the Covid-19 is Affecting the Clinical Trials of Drugs and Vaccines Industry
1.6.1.1 Clinical Trials of Drugs and Vaccines Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Clinical Trials of Drugs and Vaccines Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Clinical Trials of Drugs and Vaccines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Clinical Trials of Drugs and Vaccines Market Perspective (2015-2026)
2.2 Clinical Trials of Drugs and Vaccines Growth Trends by Regions
2.2.1 Clinical Trials of Drugs and Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Clinical Trials of Drugs and Vaccines Historic Market Share by Regions (2015-2020)
2.2.3 Clinical Trials of Drugs and Vaccines Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Clinical Trials of Drugs and Vaccines Market Growth Strategy
2.3.6 Primary Interviews with Key Clinical Trials of Drugs and Vaccines Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trials of Drugs and Vaccines Players by Market Size
3.1.1 Global Top Clinical Trials of Drugs and Vaccines Players by Revenue (2015-2020)
3.1.2 Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Players (2015-2020)
3.1.3 Global Clinical Trials of Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Clinical Trials of Drugs and Vaccines Market Concentration Ratio
3.2.1 Global Clinical Trials of Drugs and Vaccines Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Clinical Trials of Drugs and Vaccines Revenue in 2019
3.3 Clinical Trials of Drugs and Vaccines Key Players Head office and Area Served
3.4 Key Players Clinical Trials of Drugs and Vaccines Product Solution and Service
3.5 Date of Enter into Clinical Trials of Drugs and Vaccines Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Clinical Trials of Drugs and Vaccines Historic Market Size by Type (2015-2020)
4.2 Global Clinical Trials of Drugs and Vaccines Forecasted Market Size by Type (2021-2026)
5 Clinical Trials of Drugs and Vaccines Breakdown Data by Application (2015-2026)
5.1 Global Clinical Trials of Drugs and Vaccines Market Size by Application (2015-2020)
5.2 Global Clinical Trials of Drugs and Vaccines Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Clinical Trials of Drugs and Vaccines Market Size (2015-2020)
6.2 Clinical Trials of Drugs and Vaccines Key Players in North America (2019-2020)
6.3 North America Clinical Trials of Drugs and Vaccines Market Size by Type (2015-2020)
6.4 North America Clinical Trials of Drugs and Vaccines Market Size by Application (2015-2020)
7 Europe
7.1 Europe Clinical Trials of Drugs and Vaccines Market Size (2015-2020)
7.2 Clinical Trials of Drugs and Vaccines Key Players in Europe (2019-2020)
7.3 Europe Clinical Trials of Drugs and Vaccines Market Size by Type (2015-2020)
7.4 Europe Clinical Trials of Drugs and Vaccines Market Size by Application (2015-2020)
8 China
8.1 China Clinical Trials of Drugs and Vaccines Market Size (2015-2020)
8.2 Clinical Trials of Drugs and Vaccines Key Players in China (2019-2020)
8.3 China Clinical Trials of Drugs and Vaccines Market Size by Type (2015-2020)
8.4 China Clinical Trials of Drugs and Vaccines Market Size by Application (2015-2020)
9 Japan
9.1 Japan Clinical Trials of Drugs and Vaccines Market Size (2015-2020)
9.2 Clinical Trials of Drugs and Vaccines Key Players in Japan (2019-2020)
9.3 Japan Clinical Trials of Drugs and Vaccines Market Size by Type (2015-2020)
9.4 Japan Clinical Trials of Drugs and Vaccines Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Clinical Trials of Drugs and Vaccines Market Size (2015-2020)
10.2 Clinical Trials of Drugs and Vaccines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Clinical Trials of Drugs and Vaccines Market Size by Type (2015-2020)
10.4 Southeast Asia Clinical Trials of Drugs and Vaccines Market Size by Application (2015-2020)
11 India
11.1 India Clinical Trials of Drugs and Vaccines Market Size (2015-2020)
11.2 Clinical Trials of Drugs and Vaccines Key Players in India (2019-2020)
11.3 India Clinical Trials of Drugs and Vaccines Market Size by Type (2015-2020)
11.4 India Clinical Trials of Drugs and Vaccines Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Clinical Trials of Drugs and Vaccines Market Size (2015-2020)
12.2 Clinical Trials of Drugs and Vaccines Key Players in Central & South America (2019-2020)
12.3 Central & South America Clinical Trials of Drugs and Vaccines Market Size by Type (2015-2020)
12.4 Central & South America Clinical Trials of Drugs and Vaccines Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Quintiles IMS
13.1.1 Quintiles IMS Company Details
13.1.2 Quintiles IMS Business Overview and Its Total Revenue
13.1.3 Quintiles IMS Clinical Trials of Drugs and Vaccines Introduction
13.1.4 Quintiles IMS Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020))
13.1.5 Quintiles IMS Recent Development
13.2 Paraxel International Corporation
13.2.1 Paraxel International Corporation Company Details
13.2.2 Paraxel International Corporation Business Overview and Its Total Revenue
13.2.3 Paraxel International Corporation Clinical Trials of Drugs and Vaccines Introduction
13.2.4 Paraxel International Corporation Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020)
13.2.5 Paraxel International Corporation Recent Development
13.3 Charles River Laboratories
13.3.1 Charles River Laboratories Company Details
13.3.2 Charles River Laboratories Business Overview and Its Total Revenue
13.3.3 Charles River Laboratories Clinical Trials of Drugs and Vaccines Introduction
13.3.4 Charles River Laboratories Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020)
13.3.5 Charles River Laboratories Recent Development
13.4 ICON Plc
13.4.1 ICON Plc Company Details
13.4.2 ICON Plc Business Overview and Its Total Revenue
13.4.3 ICON Plc Clinical Trials of Drugs and Vaccines Introduction
13.4.4 ICON Plc Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020)
13.4.5 ICON Plc Recent Development
13.5 SGS SA
13.5.1 SGS SA Company Details
13.5.2 SGS SA Business Overview and Its Total Revenue
13.5.3 SGS SA Clinical Trials of Drugs and Vaccines Introduction
13.5.4 SGS SA Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020)
13.5.5 SGS SA Recent Development
13.6 Pharmaceutical Product Development, LLC
13.6.1 Pharmaceutical Product Development, LLC Company Details
13.6.2 Pharmaceutical Product Development, LLC Business Overview and Its Total Revenue
13.6.3 Pharmaceutical Product Development, LLC Clinical Trials of Drugs and Vaccines Introduction
13.6.4 Pharmaceutical Product Development, LLC Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020)
13.6.5 Pharmaceutical Product Development, LLC Recent Development
13.7 Wuxi AppTec Inc.
13.7.1 Wuxi AppTec Inc. Company Details
13.7.2 Wuxi AppTec Inc. Business Overview and Its Total Revenue
13.7.3 Wuxi AppTec Inc. Clinical Trials of Drugs and Vaccines Introduction
13.7.4 Wuxi AppTec Inc. Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020)
13.7.5 Wuxi AppTec Inc. Recent Development
13.8 PRA Health Sciences
13.8.1 PRA Health Sciences Company Details
13.8.2 PRA Health Sciences Business Overview and Its Total Revenue
13.8.3 PRA Health Sciences Clinical Trials of Drugs and Vaccines Introduction
13.8.4 PRA Health Sciences Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020)
13.8.5 PRA Health Sciences Recent Development
13.9 Chiltern International Ltd.
13.9.1 Chiltern International Ltd. Company Details
13.9.2 Chiltern International Ltd. Business Overview and Its Total Revenue
13.9.3 Chiltern International Ltd. Clinical Trials of Drugs and Vaccines Introduction
13.9.4 Chiltern International Ltd. Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020)
13.9.5 Chiltern International Ltd. Recent Development
13.10 INC Research
13.10.1 INC Research Company Details
13.10.2 INC Research Business Overview and Its Total Revenue
13.10.3 INC Research Clinical Trials of Drugs and Vaccines Introduction
13.10.4 INC Research Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020)
13.10.5 INC Research Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Clinical Trials of Drugs and Vaccines Key Market Segments
Table 2. Key Players Covered: Ranking by Clinical Trials of Drugs and Vaccines Revenue
Table 3. Ranking of Global Top Clinical Trials of Drugs and Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Clinical Trials of Drugs and Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Phase I
Table 6. Key Players of Phase II
Table 7. Key Players of Phase III
Table 8. Key Players of Phase IV
Table 9. COVID-19 Impact Global Market: (Four Clinical Trials of Drugs and Vaccines Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Clinical Trials of Drugs and Vaccines Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Clinical Trials of Drugs and Vaccines Players to Combat Covid-19 Impact
Table 14. Global Clinical Trials of Drugs and Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Clinical Trials of Drugs and Vaccines Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Clinical Trials of Drugs and Vaccines Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Clinical Trials of Drugs and Vaccines Market Share by Regions (2015-2020)
Table 18. Global Clinical Trials of Drugs and Vaccines Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Clinical Trials of Drugs and Vaccines Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Clinical Trials of Drugs and Vaccines Market Growth Strategy
Table 24. Main Points Interviewed from Key Clinical Trials of Drugs and Vaccines Players
Table 25. Global Clinical Trials of Drugs and Vaccines Revenue by Players (2015-2020) (Million US$)
Table 26. Global Clinical Trials of Drugs and Vaccines Market Share by Players (2015-2020)
Table 27. Global Top Clinical Trials of Drugs and Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Trials of Drugs and Vaccines as of 2019)
Table 28. Global Clinical Trials of Drugs and Vaccines by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Clinical Trials of Drugs and Vaccines Product Solution and Service
Table 31. Date of Enter into Clinical Trials of Drugs and Vaccines Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Clinical Trials of Drugs and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 34. Global Clinical Trials of Drugs and Vaccines Market Size Share by Type (2015-2020)
Table 35. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Type (2021-2026)
Table 36. Global Clinical Trials of Drugs and Vaccines Market Size Share by Application (2015-2020)
Table 37. Global Clinical Trials of Drugs and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 38. Global Clinical Trials of Drugs and Vaccines Market Size Share by Application (2021-2026)
Table 39. North America Key Players Clinical Trials of Drugs and Vaccines Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Clinical Trials of Drugs and Vaccines Market Share (2019-2020)
Table 41. North America Clinical Trials of Drugs and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 42. North America Clinical Trials of Drugs and Vaccines Market Share by Type (2015-2020)
Table 43. North America Clinical Trials of Drugs and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 44. North America Clinical Trials of Drugs and Vaccines Market Share by Application (2015-2020)
Table 45. Europe Key Players Clinical Trials of Drugs and Vaccines Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Clinical Trials of Drugs and Vaccines Market Share (2019-2020)
Table 47. Europe Clinical Trials of Drugs and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Clinical Trials of Drugs and Vaccines Market Share by Type (2015-2020)
Table 49. Europe Clinical Trials of Drugs and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Clinical Trials of Drugs and Vaccines Market Share by Application (2015-2020)
Table 51. China Key Players Clinical Trials of Drugs and Vaccines Revenue (2019-2020) (Million US$)
Table 52. China Key Players Clinical Trials of Drugs and Vaccines Market Share (2019-2020)
Table 53. China Clinical Trials of Drugs and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 54. China Clinical Trials of Drugs and Vaccines Market Share by Type (2015-2020)
Table 55. China Clinical Trials of Drugs and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 56. China Clinical Trials of Drugs and Vaccines Market Share by Application (2015-2020)
Table 57. Japan Key Players Clinical Trials of Drugs and Vaccines Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Clinical Trials of Drugs and Vaccines Market Share (2019-2020)
Table 59. Japan Clinical Trials of Drugs and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Clinical Trials of Drugs and Vaccines Market Share by Type (2015-2020)
Table 61. Japan Clinical Trials of Drugs and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Clinical Trials of Drugs and Vaccines Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Clinical Trials of Drugs and Vaccines Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Clinical Trials of Drugs and Vaccines Market Share (2019-2020)
Table 65. Southeast Asia Clinical Trials of Drugs and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Clinical Trials of Drugs and Vaccines Market Share by Type (2015-2020)
Table 67. Southeast Asia Clinical Trials of Drugs and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Clinical Trials of Drugs and Vaccines Market Share by Application (2015-2020)
Table 69. India Key Players Clinical Trials of Drugs and Vaccines Revenue (2019-2020) (Million US$)
Table 70. India Key Players Clinical Trials of Drugs and Vaccines Market Share (2019-2020)
Table 71. India Clinical Trials of Drugs and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 72. India Clinical Trials of Drugs and Vaccines Market Share by Type (2015-2020)
Table 73. India Clinical Trials of Drugs and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 74. India Clinical Trials of Drugs and Vaccines Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Clinical Trials of Drugs and Vaccines Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Clinical Trials of Drugs and Vaccines Market Share (2019-2020)
Table 77. Central & South America Clinical Trials of Drugs and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Clinical Trials of Drugs and Vaccines Market Share by Type (2015-2020)
Table 79. Central & South America Clinical Trials of Drugs and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Clinical Trials of Drugs and Vaccines Market Share by Application (2015-2020)
Table 81. Quintiles IMS Company Details
Table 82. Quintiles IMS Business Overview
Table 83. Quintiles IMS Product
Table 84. Quintiles IMS Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020) (Million US$)
Table 85. Quintiles IMS Recent Development
Table 86. Paraxel International Corporation Company Details
Table 87. Paraxel International Corporation Business Overview
Table 88. Paraxel International Corporation Product
Table 89. Paraxel International Corporation Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020) (Million US$)
Table 90. Paraxel International Corporation Recent Development
Table 91. Charles River Laboratories Company Details
Table 92. Charles River Laboratories Business Overview
Table 93. Charles River Laboratories Product
Table 94. Charles River Laboratories Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020) (Million US$)
Table 95. Charles River Laboratories Recent Development
Table 96. ICON Plc Company Details
Table 97. ICON Plc Business Overview
Table 98. ICON Plc Product
Table 99. ICON Plc Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020) (Million US$)
Table 100. ICON Plc Recent Development
Table 101. SGS SA Company Details
Table 102. SGS SA Business Overview
Table 103. SGS SA Product
Table 104. SGS SA Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020) (Million US$)
Table 105. SGS SA Recent Development
Table 106. Pharmaceutical Product Development, LLC Company Details
Table 107. Pharmaceutical Product Development, LLC Business Overview
Table 108. Pharmaceutical Product Development, LLC Product
Table 109. Pharmaceutical Product Development, LLC Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020) (Million US$)
Table 110. Pharmaceutical Product Development, LLC Recent Development
Table 111. Wuxi AppTec Inc. Company Details
Table 112. Wuxi AppTec Inc. Business Overview
Table 113. Wuxi AppTec Inc. Product
Table 114. Wuxi AppTec Inc. Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020) (Million US$)
Table 115. Wuxi AppTec Inc. Recent Development
Table 116. PRA Health Sciences Business Overview
Table 117. PRA Health Sciences Product
Table 118. PRA Health Sciences Company Details
Table 119. PRA Health Sciences Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020) (Million US$)
Table 120. PRA Health Sciences Recent Development
Table 121. Chiltern International Ltd. Company Details
Table 122. Chiltern International Ltd. Business Overview
Table 123. Chiltern International Ltd. Product
Table 124. Chiltern International Ltd. Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020) (Million US$)
Table 125. Chiltern International Ltd. Recent Development
Table 126. INC Research Company Details
Table 127. INC Research Business Overview
Table 128. INC Research Product
Table 129. INC Research Revenue in Clinical Trials of Drugs and Vaccines Business (2015-2020) (Million US$)
Table 130. INC Research Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clinical Trials of Drugs and Vaccines Market Share by Type: 2020 VS 2026
Figure 2. Phase I Features
Figure 3. Phase II Features
Figure 4. Phase III Features
Figure 5. Phase IV Features
Figure 6. Global Clinical Trials of Drugs and Vaccines Market Share by Application: 2020 VS 2026
Figure 7. Pharmaceutical Industry Case Studies
Figure 8. Hospital Case Studies
Figure 9. Laboratory Case Studies
Figure 10. Other Case Studies
Figure 11. Clinical Trials of Drugs and Vaccines Report Years Considered
Figure 12. Global Clinical Trials of Drugs and Vaccines Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Clinical Trials of Drugs and Vaccines Market Share by Regions: 2020 VS 2026
Figure 14. Global Clinical Trials of Drugs and Vaccines Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Clinical Trials of Drugs and Vaccines Market Share by Players in 2019
Figure 17. Global Top Clinical Trials of Drugs and Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Trials of Drugs and Vaccines as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Clinical Trials of Drugs and Vaccines Revenue in 2019
Figure 19. North America Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Quintiles IMS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Quintiles IMS Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2015-2020)
Figure 28. Paraxel International Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Paraxel International Corporation Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2015-2020)
Figure 30. Charles River Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Charles River Laboratories Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2015-2020)
Figure 32. ICON Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. ICON Plc Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2015-2020)
Figure 34. SGS SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. SGS SA Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2015-2020)
Figure 36. Pharmaceutical Product Development, LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Pharmaceutical Product Development, LLC Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2015-2020)
Figure 38. Wuxi AppTec Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Wuxi AppTec Inc. Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2015-2020)
Figure 40. PRA Health Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. PRA Health Sciences Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2015-2020)
Figure 42. Chiltern International Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Chiltern International Ltd. Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2015-2020)
Figure 44. INC Research Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. INC Research Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs